| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |